Startup
VC

The Week’s Top 10 Funding Rounds

Want to stay updated on the largest startup funding deals in 2024? Check out our curated list of $100 million-plus venture deals for U.S.-based companies on The Crunchbase Megadeals Board.

This weekly feature highlights the top 10 announced funding rounds in the U.S. each week. You can see last week’s biggest funding rounds here.

It was another strong week for big raises. Two U.S.-based startups secured funding rounds of a quarter-of-a-billion dollars or more, and eight rounds exceeded $100 million. Biotech made up nearly a third of the list, with developer platform and analytics sectors also represented.

Uniquity Bio, $300M, biotech: Leading the list is Uniquity Bio, a new company launched by Blackstone Life Sciences, receiving a $300 million investment. This clinical-stage drug development company focuses on immunology and inflammation and has an FDA-approved Phase 2 investigational new drug application for one of its medicines.

Vercel, $250M, developer platform: Vercel secured a $250 million Series E at a $3.25 billion valuation, led by Accel with participation from existing investors. The San Francisco-based platform, which helps companies develop web applications in the cloud, recently surpassed $100 million in annualized revenue and has over 1 million monthly active developers.

Sigma, $200M, analytics: Sigma, a cloud analytics startup, raised a $200 million Series D co-led by Spark Capital and Avenir Growth Capital. The new valuation of $1.5 billion marks a 60% increase from its Series C in 2021.

Restaurant365, $175M, accounting: Irvine-based Restaurant365 raised $175 million led by ICONIQ Growth. This enterprise management software provider for restaurants has raised over $438 million to date.

The Bot Company, $150M, robotics: Founded by Kyle Vogt, The Bot Company aims to develop robots to perform household chores. The $150 million seed funding came from investors including Quiet Capital and Stripe’s Collison brothers.

Weka, $140M, data: Weka secured a $140 million Series E led by Valor Equity Partners, valuing the company at $1.6 billion. The data platform facilitates faster and more efficient data movement, essential for AI projects.

Lycia Therapeutics, $107M, biotech: Lycia Therapeutics raised $106.6 million in a Series C led by Venrock Healthcare Capital Partners. The company focuses on developing therapeutics for autoimmune and inflammatory diseases.

Alkira, $100M, cloud infrastructure: Alkira, based in San Jose, closed a $100 million Series C led by Tiger Global Management. The company enables management of hybrid cloud assets.

9 (tied). Ajax Therapeutics, $95M, biotech: Ajax Therapeutics, developing a drug for bone marrow cancer, raised $95 million in a Series C led by Goldman Sachs Alternatives.

9 (tied). ByHeart, $95M, nutrition: ByHeart, an infant formula brand, secured $95 million from undisclosed investors and announced new production facilities in Oregon and Iowa, tripling its supply capacity.

Big global deals

U.S.-based startups dominated big rounds this week, with no nine-figure rounds raised globally. The largest round outside the U.S. was from Australian-based Cover Genius, which raised $80 million in a Series E.